Birdwatch Note Rating
2024-10-09 11:26:56 UTC - HELPFUL
Rated by Participant: 1EFD5D614078AA00AE0BF44819A2BBEDEDAD6D38FF7B08E8B2A8E09BB6576FD3
Participant Details
Original Note:
ワクチンの有効性は昨秋開始のxbbワクチンの有効性も下記に厚労省よりまとめられ https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_yuukousei_anzensei.html WHOは下記にオミクロン期の予防効果の数百もの研究をあげています。 https://view-hub.org/sites/default/files/2024-05/COVID19%20VE%20Studies_Forest%20Plots_Omicron.pdf なお、WHOも米CDCも欧EMAも英JVCIも最新時点で、コロナワクチンを特定対象に推奨しています。 https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice https://www.cdc.gov/covid/vaccines/stay-up-to-date.html https://www.ema.europa.eu/en/human-regulatory-overview/public-health-threats/coronavirus-disease-covid-19/covid-19-medicines/covid-19-vaccines-key-facts https://www.gov.uk/government/publications/covid-19-autumn-2024-vaccination-programme-jcvi-advice-8-april-2024/jcvi-statement-on-the-covid-19-vaccination-programme-for-autumn-2024-8-april-2024
All Note Details